Literature DB >> 16283142

Association of angiotensin-converting enzyme 2 (ACE2) gene polymorphisms with parameters of left ventricular hypertrophy in men. Results of the MONICA Augsburg echocardiographic substudy.

Wolfgang Lieb1, Jochen Graf, Anika Götz, Inke R König, Björn Mayer, Marcus Fischer, Jan Stritzke, Christian Hengstenberg, Stephan R Holmer, Angela Döring, Hannelore Löwel, Heribert Schunkert, Jeanette Erdmann.   

Abstract

Angiotensin-converting enzyme (ACE) activity is considered to be of major importance for the conversion of angiotensin (Ang) I to Ang II. Recently, a second ACE, named ACE2, has been identified. Experimental data provide evidence that ACE2 might be involved in modulating cardiac structure and function. In the present explorative study, we assessed whether polymorphisms in the ACE2 gene are related to echocardiographically determined parameters of left ventricular mass, structure or function in the general population. Five intronic single nucleotide polymorphisms (SNPs) were genotyped using the 5'-exonuclease activity (TaqMan) assay in the echocardiographic substudy of the third MONICA Augsburg survey. As ACE2 is located on the X chromosome, women and men were analysed separately. Four SNPs showed high pairwise linkage disequilibrium (rs4646156, rs879922, rs4240157 and rs233575). The minor alleles of these four SNPs were associated with higher left ventricular mass index (LVMI) and higher septal wall thickness (SWT) in men. Likewise, male carriers of a common haplotype (frequency 29.9%) consisting of the minor alleles of these four SNPs displayed higher values for LVMI and SWT than non-carriers (LVMI: TGGC 98.8+/-1.52 vs non-TGGC 94.8+/-0.99 g/m(2), p=0.027; SWT: TGGC 11.5+/-0.14 vs non-TGGC 11.1+/-0.09 mm, p=0.019). Furthermore, this haplotype was associated with an increased odds ratio (OR) for left ventricular hypertrophy (OR 3.10, p=0.006). In women, similar but less pronounced and consistent trends were observed. No association was observed between any of these SNPs and parameters of left ventricular systolic or diastolic function nor with blood pressure levels. This study provides evidence that genetic variants in the ACE2 gene may be associated with left ventricular mass, SWT and left ventricular hypertrophy in hemizygous men.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16283142     DOI: 10.1007/s00109-005-0718-5

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  35 in total

1.  Vasodilator action of angiotensin-(1-7) on isolated rabbit afferent arterioles.

Authors:  YiLin Ren; Jeffrey L Garvin; Oscar A Carretero
Journal:  Hypertension       Date:  2002-03-01       Impact factor: 10.190

2.  Associations between circulating components of the renin-angiotensin-aldosterone system and left ventricular mass.

Authors:  H Schunkert; H W Hense; M Muscholl; A Luchner; S Kürzinger; A H Danser; G A Riegger
Journal:  Heart       Date:  1997-01       Impact factor: 5.994

3.  Body composition and prevalence of left ventricular hypertrophy.

Authors:  B Kuch; H W Hense; B Gneiting; A Döring; M Muscholl; U Bröckel; H Schunkert
Journal:  Circulation       Date:  2000-07-25       Impact factor: 29.690

4.  Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension: the prospective randomized enalapril study evaluating regression of ventricular enlargement (preserve) trial.

Authors:  R B Devereux; V Palmieri; N Sharpe; V De Quattro; J N Bella; G de Simone; J F Walker; R T Hahn; B Dahlöf
Journal:  Circulation       Date:  2001-09-11       Impact factor: 29.690

5.  Aldosterone synthase (CYP11B2) -344 C/T polymorphism is associated with left ventricular structure in human arterial hypertension.

Authors:  C Delles; J Erdmann; J Jacobi; K F Hilgers; E Fleck; V Regitz-Zagrosek; R E Schmieder
Journal:  J Am Coll Cardiol       Date:  2001-03-01       Impact factor: 24.094

Review 6.  A story of two ACEs.

Authors:  Ursula Danilczyk; Urs Eriksson; Michael A Crackower; Josef M Penninger
Journal:  J Mol Med (Berl)       Date:  2003-03-28       Impact factor: 4.599

7.  Context-dependency of the relation between left ventricular mass and AGT gene variants.

Authors:  T Kuznetsova; J A Staessen; T Reineke; A Olszanecka; A Ryabikov; V Tikhonoff; K Stolarz; G Bianchi; E Casiglia; R Fagard; S-M Brand-Herrmann; K Kawecka-Jaszcz; Y Nikitin; E Brand
Journal:  J Hum Hypertens       Date:  2005-02       Impact factor: 3.012

Review 8.  Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.

Authors:  V Palmieri; R B Devereux
Journal:  Minerva Cardioangiol       Date:  2002-06       Impact factor: 1.347

9.  Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis.

Authors:  E O Weinberg; F J Schoen; D George; Y Kagaya; P S Douglas; S E Litwin; H Schunkert; C R Benedict; B H Lorell
Journal:  Circulation       Date:  1994-09       Impact factor: 29.690

10.  ACE2 gene expression is up-regulated in the human failing heart.

Authors:  Andrew B Goulter; Martin J Goddard; Jennifer C Allen; Kenneth L Clark
Journal:  BMC Med       Date:  2004-05-19       Impact factor: 8.775

View more
  43 in total

Review 1.  Role of ACE2 in diastolic and systolic heart failure.

Authors:  Wang Wang; Sreedhar Bodiga; Subhash K Das; Jennifer Lo; Vaibhav Patel; Gavin Y Oudit
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

Review 2.  Evolving molecular diagnostics for familial cardiomyopathies: at the heart of it all.

Authors:  Thomas E Callis; Brian C Jensen; Karen E Weck; Monte S Willis
Journal:  Expert Rev Mol Diagn       Date:  2010-04       Impact factor: 5.225

3.  Advances in the renin angiotensin system focus on angiotensin-converting enzyme 2 and angiotensin-(1-7).

Authors:  Carlos M Ferrario; Sarfaraz Ahmad; Janae Joyner; Jasmina Varagic
Journal:  Adv Pharmacol       Date:  2010

4.  Clinical impact of echocardiography parameters and molecular biomarkers in heart failure: Correlation of ACE2 and MCP-1 polymorphisms with echocardiography parameters: A comparative study.

Authors:  Mălina Suciu-Petrescu; Anamaria Truta; Mihai Domnutiu Suciu; Adrian Pavel Trifa; Denisa Petrescu; Horia Ștefan Roșianu; Octavia Sabin; Daciana Elena Popa; Antonia Eugenia Macarie; Ștefan Cristian Vesa; Anca Dana Buzoianu
Journal:  Exp Ther Med       Date:  2021-04-28       Impact factor: 2.447

Review 5.  Recombinant human angiotensin-converting enzyme 2 as a new renin-angiotensin system peptidase for heart failure therapy.

Authors:  Gavin Y Oudit; Josef M Penninger
Journal:  Curr Heart Fail Rep       Date:  2011-09

Review 6.  Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart Failure.

Authors:  Vaibhav B Patel; Jiu-Chang Zhong; Maria B Grant; Gavin Y Oudit
Journal:  Circ Res       Date:  2016-04-15       Impact factor: 17.367

7.  The Association of African Ancestry and elevated creatinine in the Coronary Artery Risk Development in Young Adults (CARDIA) Study.

Authors:  Carmen A Peralta; Neil Risch; Feng Lin; Michael G Shlipak; Alex Reiner; Elad Ziv; Hua Tang; David Siscovick; Kirsten Bibbins-Domingo
Journal:  Am J Nephrol       Date:  2009-12-21       Impact factor: 3.754

8.  Genetic variation in angiotensin-converting enzyme 2 gene is associated with extent of left ventricular hypertrophy in hypertrophic cardiomyopathy.

Authors:  Lize van der Merwe; Ruben Cloete; Miriam Revera; Marshall Heradien; Althea Goosen; Valerie A Corfield; Paul A Brink; Johanna C Moolman-Smook
Journal:  Hum Genet       Date:  2008-06-17       Impact factor: 4.132

Review 9.  ACE2 and Microbiota: Emerging Targets for Cardiopulmonary Disease Therapy.

Authors:  Colleen T Cole-Jeffrey; Meng Liu; Michael J Katovich; Mohan K Raizada; Vinayak Shenoy
Journal:  J Cardiovasc Pharmacol       Date:  2015-12       Impact factor: 3.105

10.  Soluble angiotensin-converting enzyme 2 in human heart failure: relation with myocardial function and clinical outcomes.

Authors:  Slava Epelman; Kevin Shrestha; Richard W Troughton; Gary S Francis; Subha Sen; Allan L Klein; W H Wilson Tang
Journal:  J Card Fail       Date:  2009-03-17       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.